Craig Lipset, Pfizer
Head of Clinical Innovation
Craig Lipset Biography
Craig H. Lipset is Head of Clinical Innovation within Global Product Development at Pfizer. Craig’s team is responsible for defining and creating the future of clinical development through digital tools, patient engagement, and novel collaborations. He serves on the Board of Directors for the Foundation for Sarcoidosis Research, the Board of Directors for the MedStar Health Research Institute, the Operations Committee for TransCelerate BioPharma, Chair of the Advisory Committee for North America for the DIA, and as a Mentor at health tech accelerator Blueprint Health. Most recently Craig was named to the board for the People Centered Research Foundation, created to sustain and grow the PCORnet national data network for clinical research. Craig also serves on the Editorial Board for Therapeutic Innovation & Regulatory Science, and has been listed among the PharmaVOICE most inspiring people in the life sciences, Pharmaceutical Executive’s Emerging Leaders, and AlleyWatch Who's Who in eHealth.
Craig previously served as Venture Partner in Pfizer Venture Investments as well as Senior Director in Molecular Medicine within Pfizer R&D. Prior to Pfizer he served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International).